Industry News, Regulations

ACI Provides Comments to FDA on Topical Antiseptics Program

Calls for clearer Agency feedback to industry and a pathway for dispute resolution.

Author Image

By: Christine Esposito

Editor-in-Chief

The American Cleaning Institute (ACI) provided comments to the US Food and Drug Administration (FDA) at the Agency’s Over-The-Counter Monograph Drug User Fee Program (OMUFA) Reauthorization Public Meeting on November 20. The meeting was held at the FDA Headquarters at the White Oak Campus in Silver Spring, MD.Dr. James Kim, ACI SVP, science and regulatory affairs, provided comments regarding the Topical Antiseptics Program, focusing on getting clearer feedback from FDA on GRAS/E expectations, an...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters